← EU FEED

Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences

AI BRIEFING

  • Biogen to share new SMA data at Muscular Dystrophy Association and SMA Europe conferences.
  • Company will present updates from its spinal muscle atrophy research programs.
  • Presentations will include high dose nusinersen and salanersen trials.
ADVERTISEMENT
READ ORIGINAL ARTICLE